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Abstract
Several genome-wide association studies (GWAS) have demonstrated that common genetic
variants contribute to obesity. However, studies of this complex trait have focused on ancestrally
European populations, despite the high prevalence of obesity in some minority groups. As part of
the ‘Population Architecture using Genomics and Epidemiology (PAGE)’ Consortium, we
investigated the association between thirteen GWAS-identified SNPs and BMI and obesity in
69,775 subjects, including 6,149 American Indians, 15,415 African-Americans, 2,438 East Asians,
7,346 Hispanics, 604 Pacific Islanders, and 37,823 European Americans. For the BMI-increasing
allele of each SNP, we calculated beta coefficients using linear regression (for BMI) and risk
estimates using logistic regression (for obesity defined as BMI ≥ 30) followed by fixed-effects
meta-analysis to combine results across PAGE sites. Analyses stratified by racial/ethnic group
assumed an additive genetic model and adjusted for age, sex, and current smoking. We defined
“replicating SNPs” (in European Americans) and “generalizing SNPs” (in other racial/ethnic
groups) as those associated with an allele frequency-specific increase in BMI. By this definition,
we replicated 9/13 SNP associations (5 out of 8 loci) in European Americans. We also generalized
8/13 SNP associations (5/8 loci) in East Asians, 7/13 (5/8 loci) in African Americans, 6/13 (4/8
loci) in Hispanics, 5/8 in Pacific Islanders (5/8 loci), and 5/9 (4/8 loci) in American Indians.
Linkage disequilibrium patterns suggest that tagSNPs selected for European Americans may not
adequately tag causal variants in other ancestry groups. Accordingly, fine-mapping in large
samples is needed to comprehensively explore these loci in diverse populations.
Background
Obesity is a global health problem, with over 400 million obese adults worldwide[1]. In the
US alone, there are over 60 million obese men and women, and obesity is increasingly
prevalent among children[2, 3]. Risk factors for obesity in the US include increased age,
female sex, and certain minority ancestry groups[2]. Many serious health conditions in the
developed world are associated with obesity, including stroke, coronary heart disease, type 2
diabetes mellitus, hypertension, certain cancers, and cardiovascular diseases. Thus, the
serious public health implications of unhealthy levels of body fat necessitate the need for
deeper understanding of the etiology of obesity.
Several measures of body composition are commonly used in epidemiologic studies,
including percentage body fat, waist-to-hip ratio, and body mass index (BMI, calculated as
weight (kg) ÷ height (m)2). Although the term “obesity” is often used generally to describe a
state of excess adipose tissue, the World Health Organization (WHO) defines obesity as
having a BMI of equal or greater than 30 kg/m2 [1]. Variation in body fat and body
composition may have a substantial genetic component, with numerous family studies
demonstrating that much of the variation in BMI-related measures is heritable [4]. Indeed,
our understanding of the role of genetic susceptibility to obesity and the consequences of
obesity has increased enormously in recent years as new genotyping technologies have
become accessible. First evidence came from linkage and candidate gene studies identifying
variants associated with obesity[5]. More recently, genome-wide association studies
(GWAS) and replication studies have identified multiple genetic variants across a range of
loci that were otherwise unsuspected to be associated with BMI [3, 6–18]. These scans were
primarily performed in populations of European ancestry, and while multiple variants of
interest have been identified, none explain a substantial amount of population variation in
BMI [19].
Investigation of the clinical and public health implications of these genetic discoveries
requires not only confirmation in white populations, but importantly generalization of these
associations to other ancestries such as African-Americans, Asians, American Indians, and
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other groups that were not adequately represented in the early GWAS. The purpose of this
study is to examine 69,775 participants from diverse racial and ethnic backgrounds as part of
the NHGRI-supported ‘Population Architecture using Genomics and Epidemiology
(PAGE)’ Consortium to investigate the magnitude and consistency of associations between
single-nucleotide polymorphisms (SNPs) previously-identified in genome-wide scans for
loci associated with BMI and obesity.
Methods
Study Populations
PAGE involves several studies, described briefly below and in greater detail in the
Supplementary Methods and at the PAGE website (https://www.pagestudy.org). All studies
collected self-identified racial/ethnic group via questionnaire. All studies were approved by
Institutional Review Boards at their respective sites, and all participants provided informed
consent.
Causal Variants across the Life Course (CALiCo) is a consortium of six demographically
diverse population based studies and a central laboratory, and includes approximately
58,000 men and women ranging in age from adolescence to older adulthood. Five CALiCo
studies were involved in the present analysis, and contributed data on a total of 30,291
subjects aged 18 and older: Atherosclerosis Risk in Communities Study (ARIC) (N =
15,525) [20], Coronary Artery Risk in Young Adults (CARDIA) (N = 3,508) [21],
Cardiovascular Health Study (CHS) (N = 5,273) [22], Strong Heart Family Study (SHFS) (N
= 3,202) [23], and Strong Heart Cohort Study (SHS) (N = 2,846) [24]. In addition to the
studies involved in the CALiCo consortium, PAGE includes three other large studies. The
Women’s Health Initiative (WHI) is a prospective cohort study investigating post-
menopausal women’s health in the U.S [25]. Out of the 161,808 women enrolled in WHI,
19,666 were selected and included in the present study. The Multiethnic Cohort (MEC) is a
population-based prospective cohort study of over 215,000 men and women in Hawaii and
California aged 45–75 at baseline (1993–1996) and primarily of five ancestries [26].
Participants eligible for the present study were controls in nested case-control studies of
breast, colorectal, or prostate cancer or for biomarker studies (N=7,216). Finally, this
analysis included data from the Epidemiologic Architecture for Genes Linked to
Environment (EAGLE) study. EAGLE accesses the genetic component of three National
Health and Nutrition Examination Surveys (NHANES): NHANES III (phase 2 collected
between 1991 and 1994), NHANES 1999–2000, and NHANES 2001–2002[27–29]. Overall,
12,539 NHANES participants aged 18 and older were included in these analyses.
At all PAGE sites, we did not select underweight (BMI<18.5 kg/m2) and extremely
overweight (BMI>70 kg/m2) individuals with the assumption that these extremes could be
attributable to data coding errors, an underlying illness or possibly to a familial syndrome
and hence, a rare mutation. After applying the above selection criteria, a total of 69,775
participants were selected from the PAGE consortium for analysis.
Anthropometric measurements
In all PAGE sites except MEC, BMI was calculated from height and weight measured at
time of study enrollment in a clinic setting. Measurements collected 1 or 3 years after
enrollment were substituted for 140 WHI participants missing enrollment height and/or
weight. In MEC, self-reported height and weight were used to calculate baseline BMI. Pilot
analyses within MEC have established the validity of self-reported height and weight in that
cohort. In a small validation study among white and Japanese American women in the MEC,
BMI was under-estimated based on self-reported compared to measured weight, but the
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difference was small (< 1 BMI unit; data not shown) and comparable to the findings from
national surveys [30].
SNP Selection and Genotyping
Thirteen SNPs in 8 genes previously associated with BMI were selected for genotyping
based on prior GWAS findings of positive association with BMI or obesity. SNPs were
selected from GWAS studies published online as of December 31, 2008. While
Supplementary Table 1 lists multiple studies previously investigating these SNPs, 5 papers
were used in the selection process. These were Willer et al., 2009[8], Thorleifsson et al.,
2009[12], Loos et al. 2008[6], Hinney et al. 2007[10], and Scuteri et al. 2007[11]. We were
unable to select all putative obesity-related SNPs from all 5 papers, so we implemented a
hierarchical selection strategy. First, we selected all nine SNPs associated with BMI in
Willer et al., which was the largest study under consideration (N>70–80,000 subjects).
Second, we assumed that SNPs associated with obesity in multiple GWAS were likely
targets for our replication study, and this selected one additional SNP that was associated
with BMI in three prior studies (rs8050136/FTO). We also noted that SNPs at the FTO locus
were associated with BMI in each of the 5 prior GWAS. Because multiple hits in FTO could
indicate shared linkage disequilibrium (LD) with an unmeasured causal SNP, we selected
the FTO SNP with the strongest effect in each GWAS, if it had not already been selected
(rs3751812 from Thorleifsson et al., and rs9930506 from Scuteri et al.). Finally, we noted
that SNPs at the MC4R locus were associated with BMI in several prior GWAS, and elected
to include an additional SNP at that locus. Having already selected the top MC4R hit from
Loos et al. and Willer et al. (rs17782313), as a second SNP we selected the top MC4R hit
from Thorleifsson et al. (rs12970134) for grand total of 13 genome-wide significant SNPs.
Because LD patterns often vary between racial/ethnic groups, we elected to genotype more
than one SNP in FTO and MC4R to maximize our chance of generalizing associations to
non-European subjects at these most promising loci. All 13 SNPs were genotyped in all
racial/ethnic groups, with the exception of the Pacific Islander group and American Indian
groups, for which 8 and 9 SNPs were genotyped, respectively.
We also had access to genotype data for an additional 7 SNPs associated with BMI or
obesity in prior GWAS, but not reaching genome-wide significance in a large sample of
European American subjects at commonly accepted p-value of 5 × 10−8. Because these
SNPs (rs7566605/INSIG2, rs748192/3p26.1, rs10498767/RCAN2, rs1106683/7q32.3,
rs6602024/PFKP, rs1333026/13q21.32, and rs6013029/CTNNBL1) may represent false
positive findings, analysis results are located in Supplementary Tables 5 and 6, but are not
discussed in this manuscript.
DNA extraction and genotyping methods are detailed in the Supplementary Methods.
Briefly, each PAGE site employed different genotyping platforms, with similar quality
control criteria. CALiCo sites used TaqMan, the Illumina 370CNV BeadChip, and the
Affymetrix Genome-Wide Human SNP Array 6.0. Thus, a portion of SNP genotype data
was obtained from prior GWAS of CALiCo subjects [31]. EAGLE used Sequenom’s
iPLEX® Gold coupled with MassARRAY MALDI-TOF MS detection and Illumina’s
BeadXpress with a custom GoldenGate genotyping assay. MEC used Applied Biosystems
OpenArray and TaqMan. WHI used Illumina BeadXpress with the Veracode GoldenGate
genotyping assay. All sites used appropriate internal and external controls, and excluded
genotypes deviating from Hardy-Weinberg expectations or with low concordance (typically,
<95% – 99%). In addition to site-specific quality control, all PAGE study sites genotyped
360 DNA samples from the International HapMap Project and submitted these data to the
PAGE Coordinating Center for concordance checks [32].
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Statistical analysis
We investigated continuous BMI (kg/m2) and binary obesity (defined as BMI ≥ 30).
Because the distribution of BMI was non-normal (skewed towards higher BMI), all analyses
used natural-log transformed BMI. The association between each SNP and natural log-
transformed BMI (lnBMI) was estimated using linear regression with robust standard errors
(SEs)[33]. For the association between SNPs and obesity we used logistic regression with
robust SEs[34]. SNP genotype was coded assuming an additive genetic model (i.e., 0, 1, or 2
copies of the BMI-increasing allele). All analyses were stratified by self-identified racial/
ethnic group, and adjusted for the effects of age (continuous) and sex. We also adjusted for
current smoking (yes/no) as smokers are less likely to be overweight[2]. All models
included sex*smoking and sex*age interaction terms to account for possible effect
modification by sex.
Analyses were performed for each PAGE study separately and results (effect sizes and
robust SEs) were combined with fixed-effects meta-analysis using METAL[35]. Family data
from the SHFS was analyzed using mixed models (variance component models) to account
for relatedness. These mixed models are not amenable to analysis of binary variables, thus
subjects from SHFS were excluded from the obesity analyses. Approximately 13% of the
overall WHI study cohort was selected to contribute to PAGE. This selection was non-
random, and was enriched for subjects with certain incident health conditions (diabetes,
cardiovascular disease, and stroke), non-European American race/ethnicity, and BMI>40.
Therefore, analyses of WHI data incorporated inverse probability weighting to account for
this sampling strategy.
Fixed-effects meta-analysis was used to calculate effect sizes (β for lnBMI and log OR for
obesity) and 95% confidence intervals for each SNP by racial/ethnic group. Meta-analyses
for which the combined N was fewer than 150 subjects were not performed. We evaluated I2
as a measure of heterogeneity[36], to describe the presence or absence of excess variation
between the PAGE cohorts. As a sensitivity analysis, we repeated the meta-analyses after
excluding results from subjects with self-reported height and weight (i.e., MEC subjects)
and compared these effect sizes and p-values with those from the metaanalyses with all
subjects included. A second sensitivity analysis explored using different BMI cutoffs for
exclusion from the analyses. In the subset of subjects from WHI and ARIC, we repeated
analyses excluding subjects with BMI ≥50 and ≥40.
To investigate possible correlations between multiple SNPs genotyped at a single locus, we
calculated the pairwise r2 for 2 SNPs in MC4R and 5 SNPs in FTO. We also compared
racial/ethnic-specific linkage disequilibrium (LD) patterns for selected FTO SNPs in
HaploView 4.2 (Broad Institute, Cambridge, MA) using data from the International HapMap
Project (Version 3, Release R2), specifically the HapMap African Ancestry in Southwestern
USA (ASW) analysis panel and the Centre d’Etude du Polymorphisme Humain Utah
Residents with Northern and Western European Ancestry (CEU) analysis panel.
Finally, to address the issue of population stratification, we repeated the site-specific
analyses for WHI, ARIC, and MEC including the top principal components (PCs) derived
from ancestry informative markers (AIMs) in each model, and compared the results to
models unadjusted for AIMs. Each PAGE site independently calculated PCs for all racial/
ethnic groups combined using the EIGENSTRAT method[37]. The number of PCs required
to account for population stratification varied by PAGE site, thus WHI analyses were
adjusted for the top 3 PCs, MEC analyses were adjusted for the top 4 PCs, and ARIC
analyses were adjusted for the top 10 PCs. The other PAGE sites did not have AIMs data,
and were not included in this sub-analysis.
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We used regression coefficients (betas) and 95% confidence intervals from each meta-
analysis of lnBMI to calculate the racial/ethnic group-specific difference in BMI associated
with one copy of the BMIincreasing allele, using the weighted average of BMIs from each
PAGE site to estimate the mean BMI in each racial/ethnic group. The formula used was:
mean BMI with 1 copy of risk allele = exp [ln(population mean BMI) + beta]. We
subtracted the overall population mean from the formula output, to obtain the per-allele
difference in BMI associated with each SNP. In this way, we are able to discuss differences
in mean BMI without running analyses on the untransformed (and thus skewed) raw BMI
variable. To ease interpretation, we selected a set of arbitrary thresholds to aid in
distinguishing null results from small, yet relevant effects, using different thresholds based
on minor allele frequencies (MAF). Using MAF-based thresholds helps to account for the
fact that allele frequencies vary between racial/ethnic groups, and that the strength of
association tends to increase with decreases in allele frequency (i.e., rarer alleles may be
associated with stronger effects). For interpretation, we evaluated results in terms of
absolute BMI units (kg/m2). For SNPs with MAF >0.25, we used a threshold of 0.1 BMI
units (kg/m2). For SNPs with MAF 10 – 25%, we used a threshold of 0.15 BMI units (kg/
m2), and for SNPs with MAF <10%, we used a threshold of 0.2 BMI units (kg/m2). As allele
frequencies often varied by race/ethnic group, different BMI thresholds were used for each
racial/ethnic group when required. We labeled meta-analysis results as “replicating” (for
European Americans) or “generalizing” (for other racial/ethnic groups) if the effect size
conferred a >0.10, >0.15, or >0.20 unit (kg/m2) difference in BMI (for MAFs >0.25, 0.10–
0.25, and <0.10, respectively). Effect sizes conferring smaller differences in BMI, or effect
sizes in the opposite direction as prior GWAS, were labeled as “not replicating” or “not
generalizing”. Statistical significance was not considered when assigning these labels.
For each racial/ethnic group, we estimated the statistical power to detect the GWAS-
reported effect sizes for each SNP (Supplementary Table 1) using Quanto (http://
hydra.usc.edu/gx/), assuming the same effect size as reported in a prior GWAS, an additive
genetic model and a two-sided test of association at p = 0.05. Power calculations were based
on allele frequencies specific to each racial/ethnic group, as listed in Table 2. When
necessary, the published effect sizes were re-calculated to obtain the appropriate beta
associated with BMI. For example, if an effect size was reported in terms of effect on
standard deviations of BMI, the published mean and SD BMI in the GWAS population were
used to estimate what the corresponding effect size would be in terms of difference in BMI
(kg/m2). The published and recalculated betas are provided in Supplementary Table 1. We
calculated a weighted average BMI across all PAGE sites, and calculated the weighted
average standard deviation for mean BMI by taking the square root of the weighted average
of the variance of BMI from each PAGE site.
Results
BMI (kg/m2) and demographic characteristics of participants in each PAGE site are detailed
in Table 1. Across all sites, participant age ranged from 18–100 years, and BMI ranged from
18.5 to 69.7. Except for the Women’s Health Initiative, all studies recruited men and
women. After reviewing the results with and without adjustment for ancestry principal
components in a smaller sample of subjects with AIMs data, we found little evidence that
population stratification affected our results (Supplementary Tables 2 and 3). Thus, the
results unadjusted for PCs are presented as the main results of the study given that not all
studies have available AIMs.
For each SNP, the per-allele difference from mean BMI (kg/m2) for each racial/ancestry
group is listed in Table 2, and illustrated in Figure 1. Meta-analyses results for lnBMI and
obesity are listed in Supplementary Table 4 and Table 3, respectively. Figure 1 shows that
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among European Americans, 9/13 SNPs replicated results from prior GWAS studies. Five
out of these nine significant SNPs resided in the FTO region, and were likely not
independent in our analysis, with pairwise r2 values ranging from 0.82 – 0.99 in European
Americans (Supplementary Table 7). An additional SNP, rs10938397/GNPDA2 (MAF =
0.43) was associated with a nominally significant (p = 0.04) 0.08 BMI-unit increase, but did
not meet our criteria for “replication” (i.e., >0.10 BMI units, kg/m2). Two SNPs were found
to alter mean BMI by less than the generalization threshold, and were not statistically
significant despite having adequate power (90 – 99%) (rs7498665/SH2B1 and rs17782313/
MC4R). One SNP (rs11084753/KCTD15) was not significantly associated with BMI, but
was likely underpowered (power = 24%).
The analyses of obesity in European Americans produced similar results, as listed in Table
3. The 5 correlated FTO SNPs were each associated with 17% increased odds of obesity. A
strong association was also observed for rs6548238/TMEM18, for which the C allele was
associated with 13% increased odds of obesity. The remaining SNPs were associated with
modest increases in odds of obesity, ranging from 0.5% to 8%.
We further analyzed these 13 SNPs to determine whether these associations generalized to
other ancestral groups, and relied upon pairwise r2 (Supplementary Table 7) to determine
whether multiple associations at the same locus were likely to be independent. In African
Americans, seven SNPs generalized results from prior GWAS. LD in the FTO region was
much lower compared to European Americans, with r2 ranging from 0.07 to 0.92 (mean r2 =
0.38). Two out of five FTO SNPs generalized in this group, but no associations were
statistically significant despite adequate power. Both MC4R SNPs generalized in African
Americans, yielding identical betas. These SNPs were not correlated (mean r2 = 0.12), and
may represent independent associations. In the analyses of obesity, we observed nominally
significant associations for 2 SNPs: rs6548238/TMEM18 (OR = 1.159, p = 0.0005) and
rs10938397/GNPDA2 (OR = 1.106, p = 0.001).
In Hispanics, six SNPs generalized results from prior GWAS. LD in the FTO region was
slightly lower compared to European Americans (r2 ranging from 0.63 – 0.91, mean = 0.75).
Analyses in Hispanics were largely underpowered, with only one SNP having greater than
80% power (rs9930506/FTO). Three out of five FTO SNPs generalized in this group,
although these 3 SNPs are moderately correlated (pairwise r2 ranging from 0.66 – 0.84) and
may not represent independent associations. In the analyses of obesity, we observed
nominally significant associations for 3 SNPs: rs10838738/MTCH2 (OR = 1.109, p = 0.01),
rs8050136/FTO (OR = 1.225, p = 0.001), and a significant inverse association for
rs12970134/GNPDA2 (OR = 0.527, p = 0.01).
In East Asians, eight SNPs generalized results from prior GWAS. Most analyses were
underpowered, with only one SNP having at least 80% power (rs8050136/FTO). Four out of
five FTO SNPs generalized in East Asians, although these SNPs are highly correlated and
unlikely to represent independent associations (r2 ranging from 0.75 – 0.99, mean = 0.87).
In the analyses of obesity, we observed nominally significant associations for 2 SNPs:
rs7498665/SH2B1 (OR = 1.846, p = 0.0005) and rs8050136/FTO (OR = 1.472, p = 0.01).
Of the eight SNPs analyzed in Pacific Islanders, five generalized results from prior GWAS,
including 1 FTO SNP, rs8050136. Power was very limited in this group, with no analysis
having more than 14% power to detect a significant association (note that results from
Pacific Islanders are not displayed in Figure 1 as they included <1000 subjects). In the
analyses of obesity, we observed a nominally significant association for 1 SNP: rs10938397/
GNPDA2 (OR = 1.512, p = 0.01).
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Of the nine SNPs analyzed in American Indians, five SNPs showed a per-allele difference in
BMI exceeding the generalization threshold in the same direction as in the initial GWAS.
Both FTO SNPs analyzed generalized in American Indians, but these SNPs are highly
correlated (r2 = 0.98), and are unlikely to represent independent associations. In the analyses
of obesity, we observed a nominally significant inverse association for 1 SNP: rs7498665/
SH2B1 (OR = 0.890, p = 0.04). This is opposite the association observed for BMI, in which
each copy of the risk allele was associated with a 0.38-unit (kg/m2) increase in BMI (p =
0.002). This discrepancy could be attributable to chance, or variation between the subjects
included in the obesity analysis (N = 2946) vs. the analysis of lnBMI (N = 6149).
We found evidence for excess heterogeneity across studies in five SNPs. There was
evidence for excess heterogeneity for two summary statistics in European Americans. The
heterogeneity p-value was 0.03 for the analyses of two FTO SNPs and obesity: rs9930506
and rs1121980. For these SNPs, the magnitude of effect sizes differed between ARIC and
WHI, the only two sites contributing data to the analyses, although the directions of effect
were the same. These FTO SNPs are highly correlated in WHI and ARIC European
Americans (r2 = 0.86 in both studies), and study-specific results yielded identical betas for
each SNP: 0.08 for both SNPs in WHI and 0.21 for both SNPs in ARIC. The heterogeneity
pvalue for rs7498665/SH2B1 and BMI was 0.03 in Hispanics, and the beta coefficients from
the three studies (EAGLE, WHI, and MEC) contributing to this meta-analysis were not
consistent (0.007, −0.005, and −0.02, respectively). Finally, in East Asians, the
heterogeneity p-value for rs10838738/MTCH2 and BMI was 0.005, and for rs7498665/
SH2B1 and obesity was 0.02. For rs10838738/MTCH2, the beta coefficients from MEC and
WHI were in opposite directions (0.01 and −0.02, respectively). The observed differences in
beta coefficients may be due to underlying genetic differences in Asian subjects in MEC
versus WHI, or because height and weight were directly measured in WHI, and self-reported
in MEC. For rs7498665/SH2B1, the beta coefficients from MEC and WHI were in the same
direction, but of different magnitudes (0.29 and 1.14, respectively).
The sensitivity analyses in European Americans and African Americans revealed that the
meta-analyses performed without subjects with self-reported height and weight produced
nearly identical effect sizes and p-values as the analyses including all subjects. However, the
sensitivity analysis in East Asian subjects revealed several associations that changed
direction after excluding subjects with self-reported height and weight (data not shown). In
addition to the underlying heterogeneity described above, this instability could be
attributable to sample size changes, because nearly two-thirds (N = 1740) of the East Asian
sample had self-reported height and weight. The sensitivity analysis comparing results using
different exclusion criteria (i.e., BMI ≥50 or BMI ≥40, rather than BMI ≥70) revealed no
systematic differences between results when different BMI exclusion cutoffs were used
(Supplementary Table 8). Effect sizes did vary, but there was no universal shift towards
stronger or weaker effects when high-BMI subjects were excluded.
Discussion
In this large study including a total of 69,775 participants from six racial/ethnic groups, we
found that 9 out of 13 SNPs (5/8 loci) genotyped in European Americans replicated results
from prior GWAS. We observed the greatest amount of generalization in East Asians (8/13
SNPs, 5/8 loci), with lesser amounts in African Americans (7/13 SNPs, 5/8 loci, Hispanics
(6/13 SNPs, 4/8 loci), Pacific Islanders (5/8 SNPs, 5/8 loci), and American Indians (5/9
SNPs, 4/8 loci).
Associations of the five SNPs in the FTO gene with lnBMI and obesity were particularly
strong in multiple racial/ethnic groups; and reached genome-wide significance at 5 × 10−8 in
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European Americans. However, these SNPs are correlated in almost all racial/ethnic groups
studied, and therefore likely represent association with a single, unmeasured causal variant.
As an illustration of LD in intron 1 of FTO, figure 2 uses HapMap data to illustrate a high
degree of correlation among the FTO SNPs in European Americans (note that HapMap data
for rs9939609 is not available, but this SNP is located between rs3751813 and rs12597786
on Figure 2). LD in the FTO region is substantially lower in African Americans (r2 from
0.07 – 0.92) versus other racial/ethnic groups, as illustrated in Figure 2 and Supplementary
Table 7. LD is likewise lower in other non-European racial/ethnic groups, but there is still
evidence for substantial correlation among most FTO SNPs in Hispanics (r2 from 0.63
−0.91), East Asians (r2 from 0.75 – 0.99) and American Indians (r2 of 0.98). A recent fine-
mapping analysis illustrated that LD at the FTO locus is much lower in African Americans
compared to European Americans, which translates to fewer FTO SNPs associated with
BMI in African Americans [38]. This LD pattern (or lack thereof) may explain lack of
generalization of several FTO SNPs in PAGE African Americans, despite sufficient power
(rs9930506 with 99% power and rs9939609 with 82% power). If rs9930506 and rs9939609
are tagging (i.e., in LD with) a true causal SNP, then lower overall LD in this region could
“decouple” the tagging SNPs from the underlying causal variant(s), leading to a true null
association between rs9930506 and rs9939609 in African Americans. Likewise, the fine-
mapping study cited above found no association between rs9939609 and BMI in African
Americans [38]. In addition, Figure 1 shows that although the directions of the associations
between the other three FTO SNPs (rs1121980, rs3751812, and rs8050136) and BMI were
the same in European Americans and African Americans, the magnitudes of effect were
substantially attenuated in African Americans, while the effect sizes observed in other racial/
ethnic groups more closely mirrored those in European Americans. Although rs8050136/
FTO was marginally associated with lnBMI in African Americans (p-value = 0.06), two
SNPs correlated with rs8050136 were not associated with lnBMI in this group despite
adequate power (rs1121980, r2 = ~0.75, p-value = 0.38; rs9939609, r2 = ~0.88, p-value =
0.70). This suggests that regions of LD span smaller portions of the FTO locus in African
Americans, compared to European Americans. Accordingly, fine-mapping is needed to
comprehensively investigate if susceptibility loci observed in European Americans are
universally important to obesity in African Americans and other minority racial/ethnic
groups. Because LD patterns are more similar between European Americans, Hispanics,
East Asians, and American Indians, fine-mapping would likely be more fruitful in limiting
the number of potentially functional variants in African Americans than in other racial/
ethnic groups.
Power limitations will become increasingly challenging for newly discovered GWAS
findings given that the “low hanging fruits” with stronger effect sizes, such as FTO, have
already been harvested in European-American populations and effect sizes of newly
discovered SNPs will become increasingly smaller. In this respect, it is not surprising that
many of the associations in minority racial/ethnic groups did not reach statistical
significance in our study, despite sizable samples sizes particularly for African Americans
(15,415), Hispanics (7,346) and American Indians (6,149). Accordingly, we did not attempt
to use a statistical significance threshold as a criterion for generalization into other racial/
ethnic groups. Rather, our definition of generalization as > 0.1, >0.15, or >0.20 unit (kg/m2)
(depending on MAF) increase in BMI are arbitrary cutoff points for the minimum
perceptible difference in BMI.
Our analyses were limited by several factors. As described above, LD patterns vary by race/
ethnicity and the SNPs selected for this analysis are almost certainly not the ideal set of
tagSNPs for each group. Second, our analyses do not account for known effect modifiers
such as diet [2]and physical activity[39], and thus additional studies are needed to
investigate the influence of the environment on the associations reported herein. Third, only
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13 SNPs in 8 loci met our criteria for inclusion in this analysis as of December 31, 2008.
Most of the SNPs under consideration were drawn from Willer et al.[8], and hence, SNP
selection was not complete. However, our aim was not to comprehensively genotype all
putative obesity-associated SNPs in non-European populations, rather, our goal was to
illustrate generalization (or lack thereof) of the most promising obesity-related SNPs to
multiple racial/ethnic groups. Including additional SNPs would have strengthened the
conclusions of our study. Since the end of 2008, numerous studies have identified additional
loci associated with BMI and obesity in European subjects. Notably, a recent GWAS
conducted in nearly 250,000 European-descent subjects identified 18 novel loci associated
with BMI, and confirmed several known associations, including two investigated in our
PAGE analysis (rs10938397/GNPDA2 and rs2815752/NEGR1)[40]. These newly-
discovered SNPs should be analyzed in large samples of non-European subjects to improve
understanding of genetic risk factors for obesity in minority populations. It is of particular
interest to note our a statistically significant association between the reported BMI-
increasing allele of rs10938397 and decreased BMI in Hispanics – this finding may be due
to chance, or to epistasis, or a gene-environment interaction specific to Hispanic
populations.
Finally, in an attempt to maximize the generalizability of these findings, we applied limited
exclusion criteria, and included individuals with BMI ranging from 18.5 to 70. We did not
exclude individuals with obesity-associated disorders such as diabetes or cardiovascular
disease. It is possible that one or more of the SNPs under study are also associated with an
obesity-related illness, and thus an underlying condition may have confounded our results.
However, diabetes and cardiovascular disease are understood to be consequences of obesity,
thus it is unlikely that an obesity-related comorbidity would confound these associations.
Further, our exploration of using stricter BMI exclusion criteria (i.e., BMI ≥ 40 kg/m2 and
BMI ≥ 50 kg/m2 did not yield any systematic changes in effect size or statistical
significance, suggesting that the effects of the SNPs in this analysis are consistent across a
wide range of BMI.
The PAGE consortium offers a unique opportunity to investigate associations between
candidate SNPs and BMI and obesity in ancestrally diverse cohorts with well-characterized
phenotypes. Although PAGE studies recruited participants in a wide age range in many
diverse regions of the United States, we observed little evidence of heterogeneity across
studies, and only five estimates had a p for heterogeneity <0.05. This not significantly
different (p = 0.08) from the number of heterogeneous estimates expected by chance alone.
The substantial strength of PAGE is the large samples of ancestrally diverse participants, in
which very little is known about genetic risk factors for obesity. However, these sample
sizes did not prove to be adequate for SNPs with very small effect sizes. Aside from
rs8050136/FTO, very few associations generalized to non-European American racial/ethnic
groups and reached statistical significance.
In conclusion, in this large and diverse study we were able to replicate and generalize
associations between 13 SNPs and BMI. The fraction of SNPs that generalized to non-
European other racial/ethnic groups varied substantially, and appeared to be somewhat
dependent on LD patterns. Failure to find statistically significant results underscores the
importance of recruiting large samples of diverse participants for genetic studies of BMI and
obesity. Race/ethnicity-based differences in LD highlight the need for fine-mapping studies
in very large samples, in order to comprehensively explore the behavior of these loci in
ancestrally diverse populations. In addition, an investigation of gene-environment
interactions may help resolve ancestry-based differences in genetic risk factors for obesity.
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Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Interpretation of association results and statistical power
Plot of per-allele difference and 95% confidence interval from the population mean BMI for
each racial/ethnic group, and statistical power for each analysis. This plot is restricted to
analyses that included at least 1000 subjects. All analyses used the BMI-increasing allele
named in prior GWAS as the risk allele; thus estimates falling above the mean BMI line are
in the same direction as prior GWAS. >Statistical power is indicated by color intensity, with
light grey indicating <50% power, medium grey boxes indicating 50–80% power, and black
boxes indicating >80% power.
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Figure 2. Linkage disequilibrium (LD) plots for FTO region in ASW and CEU HapMap analysis
panels
LD plots and were constructed in Haploview 4.2 using data from the International HapMap
Project (Version 3, Release R2). The meta-analyses presented here involved 5 FTO SNPs, 4
of which are available in HapMap data (boxed). The HapMap CEU (Centre d’Etude du
Polymorphisme Humain (Utah residents with ancestry from northern and western Europe))
analysis panel was used to represent European-ancestry individuals, and the HapMap ASW
(African Ancestry in Southwest USA) analysis panel was used to represent African-
Americans. The number in each square is the correlation coefficient (r2) for each pair of
SNPs, with darker shading indicating higher values of r2.
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Table 3
Meta-analysis of logistic re=gression of putative obesity-related SNPs and obesity, stratified by racial/ethnic
group
Gene SNP Location CA
European Americans Hispanics African Americans
Effect
Size
(95%
CI) p-value N AF
Effect
Size
(95%
CI) p-value N AF
Effect
Size
(95%
CI) p-value N AF
NEGR1 rs2815752 1p31.1 T 1.047
(0.996
–
1.100)
0.07 28261 0.63 0.997
(0.865
–
1.149)
0.97 2891 0.71 1.004
(0.942
–
1.070)
0.91 10576 0.54
TMEM18 rs6548238 2p25.3 C 1.134
(1.075
–
1.196)
3.50E-06 37061 0.83 0.959
(0.852
–
1.079)
0.49 6398 0.87 1.159
(1.067
–
1.259)
4.78E-04 14492 0.88
GNPDA2 rs10938397 4p12 G 1.027
(0.983
–
1.073)
0.23 31346 0.43 1.024
(0.942
–
1.113)
0.58 6369 0.37 1.106
(1.040
–
1.176)
0.00 14383 0.24
MTCH2 rs10838738 11p11.2 G 1.045
(1.001
–
1.091)
0.04 34679 0.35 1.109
(1.021
–
1.204)
0.01 6406 0.37 0.947
(0.868
–
1.034)
0.23 14240 0.10
SH2B1 rs7498665 16p11.2 G 1.020
(0.976
–
1.066)
0.38 31383 0.38 0.993
(0.916
–
1.077)
0.87 6391 0.44 1.032
(0.971
–
1.096)
0.31 13642 0.27
FTO rs1121980 16q12.12 A 1.173
(1.109
–
1.239)
a
1.88E-08 21645 0.43 1.260
(0.835
–
1.901)
0.27 426 0.37 1.034
(0.939
–
1.137)
0.50 4005 0.47
FTO rs3751812 16q12.12 T 1.165
(1.107
–
1.225)
2.91E-09 25776 0.51 1.095
(0.916
–
1.309)
0.32 1911 0.28 1.056
(0.899
–
1.239)
0.51 4549 0.12
FTO rs8050136 16q12.12 A 1.169
(1.112
–
1.228)
7.14E-10 26544 0.41 1.225
(1.085
–
1.384)
0.001 3674 0.30 1.053
(0.985
–
1.124)
0.13 9435 0.43
FTO rs9930506 16q12.12 G 1.174
(1.111
–
1.241)
b
1.11E-08 21998 0.44 1.161
(0.977
–
1.379)
0.09 1912 0.32 1.047
(0.953
–
1.150)
0.34 7065 0.21
FTO rs9939609 16q12.12 A 1.173
(1.117
–
1.232)
1.44E-10 28286 0.41 1.051
(0.706
–
1.564)
0.81 449 0.33 1.024
(0.947
–
1.107)
0.56 6492 0.47
MC4R rs12970134 18q22 A 1.078
(1.013
–
1.146)
0.02 21987 0.26 0.527
(0.320
–
0.866)
0.01 448 0.17 1.049
(0.911
–
1.207)
0.51 4046 0.13
MC4R rs17782313 18q22 C 1.068
(1.019
–
1.120)
0.01 35398 0.23 1.049
(0.933
–
1.179)
0.42 6388 0.13 1.048
(0.987
–
1.112)
0.12 13698 0.29
KCTD15 rs11084753 19q13.11 G 1.010
(0.961
0.69 29411 0.67 1.065
(0.931
0.36 2891 0.65 1.002
(0.939
0.96 10795 0.64
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Gene SNP Location CA
European Americans Hispanics African Americans
Effect
Size
(95%
CI) p-value N AF
Effect
Size
(95%
CI) p-value N AF
Effect
Size
(95%
CI) p-value N AF
–
1.062)
–
1.218)
–
1.070)
Gene SNP Location CA
East Asians Pacific Islanders American Indians
Effect
Size
(95%
CI) p-value N AF
Effect
Size
(95%
CI) p-value N AF
Effect
Size
(95%
CI) p-value N AF
NEGR1 rs2815752 1p31.1 T 0.688
(0.436
–
1.086)
0.11 2041 0.91 0.973
(0.638
–
1.484)
0.90 392 0.81 1.040
(0.910
–
1.188)
0.57 2926 0.78
TMEM18 rs6548238 2p25.3 C 0.900
(0.586
–
1.381)
0.63 2041 0.90 1.110
(0.606
–
2.033)
0.74 392 0.92 0.940
(0.822
–
1.073)
0.36 2950 0.75
GNPDA2 rs10938397 4p12 G 0.910
(0.683
–
1.214)
0.52 2037 0.28 1.512
(1.085
–
2.107)
0.01 392 0.27 0.974
(0.857
–
1.107)
0.69 2933 0.24
MTCH2 rs10838738 11p11.2 G 1.176
(0.900
–
1.536)
0.24 2041 0.34 1.161
(0.838
–
1.608)
0.37 392 0.34 1.019
(0.914
–
1.135)
0.74 2944 0.47
SH2B1 rs7498665 16p11.2 G 1.846
(1.306
–
2.609)
c
5.16E-04 2038 0.13 1.362
(0.970
–
1.913)
0.07 392 0.25 0.890
(0.794
–
0.997)
0.04 2946 0.58
FTO rs1121980 16q12.12 A 1.437
(0.836
–
2.472)
0.19 672 0.21
FTO rs3751812 16q12.12 T 1.607
(0.944
–
2.734)
0.08 701 0.18
FTO rs8050136 16q12.12 A 1.472
(1.109
–
1.954)
0.01 2325 0.19 1.089
(0.819
–
1.448)
0.56 574 0.24 1.029
(0.865
–
1.226)
0.74 2945 0.12
FTO rs9930506 16q12.12 G 1.315
(0.781
–
2.216)
0.30 699 0.22
FTO rs9939609 16q12.12 A 1.541
(0.908
–
2.614)
0.11 696 0.18 1.019
(0.855
–
1.216)
0.83 2928 0.12
MC4R rs12970134 18q22 A 1.653
(0.881
–
3.101)
0.12 696 0.16
MC4R rs17782313 18q22 C 1.132
(0.816
–
1.571)
0.46 2040 0.22 0.848
(0.538
–
1.337)
0.48 392 0.14 0.816
(0.624
–
1.068)
0.14 2941 0.06
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Gene SNP Location CA
East Asians Pacific Islanders American Indians
Effect
Size
(95%
CI) p-value N AF
Effect
Size
(95%
CI) p-value N AF
Effect
Size
(95%
CI) p-value N AF
KCTD15 rs11084753 19q13.11 G 1.205
(0.929
–
1.560)
0.16 2041 0.62 0.969
(0.713
–
1.318)
0.84 392 0.52 1.088
(0.968
–
1.222)
0.16 2940 0.70
CA: coded allele; AF: risk allele frequency; CI: confidence interval;
a
: heterogeneity I2 = 79.7, p-value = 0.03;
b
: heterogeneity I2 = 79.6, p-value = 0.03;
c
: heterogeneity I2 = 82.0, p-value = 0.02
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